Regulatory Affairs Services
Global strategy.Local compliance. Submission-ready execution.
EMA (EU)
- Centralized, DCP, MRP, NP submissions
- Scientific advice briefing books
- eCTD dossier preparation (Modules 1–5)
- Lifecycle management (variations, renewals, notifications)
UK (MHRA)
- National procedure & reliance routes
- eCTD dossier compilation & submission
- Pre-submission & accelerated review support
- Lifecycle activities (variations, PSURs, renewals)
US (FDA)
- Pathway assessment: 505(b)(1), 505(b)(2), ANDA
- Pre-IND & pre-NDA meeting support
- IND, DMF, ANDA, NDA dossier preparation
- ESG/eCTD publishing & SPL creation
- Responses to IR, DRL, CRL
- Labelling & SPL compliance
Special Capabilities
- EMA centralized vs. DCP/MRP guidance
- UK reliance route submissions
- 505(b)(2) strategy planning (US)
- UK Legal Representative / EU affiliate coordination
CMC Development & Strategy
- Regulatory CMC gap analysis
- CTD Module 2 & 3 authoring
- API/DP comparability assessments
Drug Substance (API)
- DMF/ASMF/CEP preparation
- Impurity profiling & reference standards
- API stability programs
Lifecycle CMC Management
- Post-approval variations & supplements
- Comparability protocols
- Renewals & ongoing compliance
